HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Noel Barrett Selected Research

OspA protein

11/2014A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
9/2013A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies.
8/2013Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
1/2013Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
2/2011A new approach to a Lyme disease vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Noel Barrett Research Topics

Disease

21Human Influenza (Influenza)
09/2014 - 08/2007
9Infections
01/2013 - 08/2010
5Influenza in Birds (Avian Flu)
01/2015 - 08/2007
5Lyme Disease (Disease, Lyme)
11/2014 - 01/2013
3Tick-Borne Encephalitis (Encephalitis, Tick Borne)
10/2011 - 12/2003
3Vaccinia
01/2011 - 08/2010
2Poliomyelitis (Polio)
01/2017 - 05/2009
2Virus Diseases (Viral Diseases)
01/2017 - 05/2009
2Chronic Disease (Chronic Diseases)
09/2014 - 06/2014
2Pain (Aches)
08/2013 - 06/2008
2Headache (Headaches)
08/2013 - 06/2008
2Fever (Fevers)
09/2012 - 06/2012
1HIV Infections (HIV Infection)
01/2017
1Weight Loss (Weight Reduction)
06/2012
1Disease Progression
04/2012
1Emerging Communicable Diseases (Emerging Infectious Diseases)
04/2012
1Hemolysis
01/2012
1Viremia
05/2011
1Yellow Fever
01/2011
1Rotavirus Infections
05/2009
1Severe Acute Respiratory Syndrome
01/2006
1Central Nervous System Diseases (CNS Diseases)
04/2003

Drug/Important Bio-Agent (IBA)

35VaccinesIBA
01/2017 - 04/2003
7Influenza Vaccines (Influenza Vaccine)FDA Link
06/2014 - 08/2007
5OspA proteinIBA
11/2014 - 02/2011
5AntibodiesIBA
09/2014 - 05/2011
4Neuraminidase (Sialidase)IBA
09/2014 - 08/2010
3Hemagglutinins (Hemagglutinin)IBA
06/2012 - 08/2010
2Intravenous Immunoglobulins (IVIG)FDA Link
04/2014 - 04/2012
2Immunoglobulins (Immunoglobulin)IBA
04/2014 - 04/2012
2Proteins (Proteins, Gene)FDA Link
01/2014 - 01/2011
1ABX464IBA
01/2017
1Antiviral Agents (Antivirals)IBA
01/2017
1EnzymesIBA
09/2014
1LectinsIBA
09/2014
1Neutralizing AntibodiesIBA
06/2014
1cyclo(Arg-Pro) (CI 4)IBA
08/2013
1EpitopesIBA
01/2013
1Immunoglobulin G (IgG)IBA
01/2013
1InterferonsIBA
05/2011
1rhesus rotavirus vaccineIBA
05/2011
1AntigensIBA
02/2011
1Inactivated VaccinesIBA
08/2010
1ACAM2000IBA
05/2009
1Viral VaccinesIBA
05/2009
1Blood Proteins (Serum Proteins)IBA
01/2006